Etodolac and Vitamin e drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Vitamin e (tocopherols and tocotrienols). Common drug interactions include cough among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Vitamin e. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Vitamin e?

Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.



On Jul, 19, 2026

90 people who take Etodolac and Vitamin e together, and have interactions are studied.

Etodolac and Vitamin e drug interactions.

What are the common drug interactions of Etodolac and Vitamin E, by gender? *:

female:

  1. Cough
  2. Dizziness
  3. Drug effect increased
  4. Dry mouth
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Ear infection
  7. Fungal infection
  8. Gait disturbance
  9. Gastrointestinal ulcer
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

  1. Insomnia (sleeplessness)
  2. Weight decreased
  3. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  4. Migraine (headache)
  5. Nausea (feeling of having an urge to vomit)
  6. Arthralgia (joint pain)
  7. Exfoliative rash (scaly red generalized skin rash)
  8. Rash pruritic (redness with itching)
  9. Stress
  10. Adverse drug reaction

What are the common drug interactions of Etodolac and Vitamin E, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Injection site reaction

30-39:

  1. Abdominal pain upper
  2. Balance disorder
  3. Dizziness
  4. Drug hypersensitivity
  5. Flatulence (flatus expelled through the anus)
  6. Frequent bowel movements
  7. Haematemesis (vomiting of blood)
  8. Haematochezia (passage of stools containing blood)
  9. Headache (pain in head)
  10. Mood altered (changes in mood)

40-49:

  1. Abnormal loss of weight
  2. Chronic kidney disease
  3. Drug effect increased
  4. Drug hypersensitivity
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastrointestinal ulcer
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Red blood cell abnormality (abnormal red blood cells)
  10. Spinal cord neoplasm (tumour of spinal cord)

50-59:

  1. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  2. Migraine (headache)
  3. Back pain
  4. Drug ineffective
  5. Exfoliative rash (scaly red generalized skin rash)
  6. Nausea (feeling of having an urge to vomit)
  7. Pyrexia (fever)
  8. Rash pruritic (redness with itching)
  9. Stress
  10. Tremor (trembling or shaking movements in one or more parts of your body)

60+:

  1. Arthralgia (joint pain)
  2. Chronic kidney disease
  3. Fall
  4. Injection site pain
  5. Insomnia (sleeplessness)
  6. Pain in extremity
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Weight increased
  10. Alopecia (absence of hair from areas of the body)

What are the existing conditions these people have? *

  1. Pain: 19 people, 21.11%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 17.78%
  3. High Blood Pressure: 16 people, 17.78%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 12.22%
  5. High Blood Cholesterol: 10 people, 11.11%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 8.89%
  7. Diabetes: 8 people, 8.89%
  8. Cardiac Disorder: 8 people, 8.89%
  9. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 6.67%
  10. Psoriasis (immune-mediated disease that affects the skin): 6 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Vitamin e?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Etodolac and Vitamin e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamin e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etodolac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamin e and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etodolac and tocopherols and tocotrienols (the active ingredients of Etodolac and Vitamin e, respectively), and Etodolac and Vitamin e (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: